Immunotherapy Combination Shown to Benefit Some Patients with Non-Small Cell Lung Cancer Resistant to Single Immunotherapy

A combination of two drugs that open the floodgates to an immune system attack on cancer curtailed tumor growth in some patients with non-small cell

Related Keywords

Wisconsin ,United States ,F Stephen Hodi ,Joleen Hubbard ,Ryanc Brennick ,Jonathan Schoenfeld ,Susannem Arnold ,Niall Lennon ,Jasonl Weirather ,Anita Giobbie Hurder ,Jamesl Abbruzzese ,Salmak Jabbour ,Catherinej Wu ,Carrie Cibuskis ,Lin Yang ,Lizac Villaruz ,Hayley Lyon ,Scottj Rodig ,Srinika Ranasinghe ,Aashna Jhaveri ,Junko Tsuji ,Mansoorm Ahmed ,Howard Streicher ,Jenniferm Johnson ,Nataliyav Uboha ,Jennifer Altreuter ,Katrinaz Kao ,Helenx Chen ,Lauren Gunasti ,Artam Monjazeb ,Yang Liu ,Ryand Gentzler ,Carrie Lee ,Kevinl Stephans ,Elad Sharon ,Markm Awad ,Duke Cancer Institute ,Broad Institute ,University Of California Davis Comprehensive Cancer Center ,National Cancer Institute ,Sidney Kimmel Cancer Center ,Rutgers Cancer Institute Of New Jersey ,University Of Kentucky Markey Cancer Center ,National Institutes Of Health ,Siteman Cancer Center ,University Of Wisconsin Carbone Cancer Center ,Washington University ,University Of Virginia Cancer Center ,Dana Farber Brigham Cancer Center ,Lancet Oncology ,Dana Farber Brigham Cancer ,California Davis Comprehensive Cancer ,Ana Lako ,Virginia Cancer Center ,Mayo Clinic ,Kentucky Markey Cancer Center ,Rutgers Cancer Institute ,New Jersey ,Wisconsin Carbone Cancer Center ,Cleveland Clinic ,Haeseong Park ,Pittsburgh Medical Center Hillman Cancer ,National Cancer ,National Institutes ,Biomarker Supplement ,